AAAAAA
Results:
1-10
|
Results: 10
Authors:
Wiseman, GA
White, CA
Sparks, RB
Erwin, WD
Podoloff, DA
Lamonica, D
Bartlett, NL
Parker, JA
Dunn, WL
Spies, SM
Belanger, R
Witzig, TE
Leigh, BR
Citation: Ga. Wiseman et al., Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin (TM) radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, CR R ONC H, 39(1-2), 2001, pp. 181-194
Authors:
DeNardo, GL
Juweid, ME
White, CA
Wiseman, GA
DeNardo, SJ
Citation: Gl. Denardo et al., Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing, CR R ONC H, 39(1-2), 2001, pp. 203-218
Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation
Authors:
Hogan, WJ
Lacy, MQ
Wiseman, GA
Fealey, RD
Dispenzieri, A
Gertz, MA
Citation: Wj. Hogan et al., Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation, BONE MAR TR, 28(3), 2001, pp. 305-309
Authors:
Fatourechi, V
Hay, ID
Mullan, BP
Wiseman, GA
Eghbali-Fatourechi, GZ
Thorson, LM
Gorman, CA
Citation: V. Fatourechi et al., Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?, THYROID, 10(7), 2000, pp. 573-577
Authors:
Wiseman, GA
White, CA
Stabin, M
Dunn, WL
Erwin, W
Dahlbom, M
Raubitschek, A
Karvelis, K
Schultheiss, T
Witzig, TE
Belanger, R
Spies, S
Silverman, DHS
Berlfein, JR
Ding, E
Grillo-Lopezs, AJ
Citation: Ga. Wiseman et al., Phase I/II Y-90-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma, EUR J NUCL, 27(7), 2000, pp. 766-777
Authors:
Krowka, MJ
Wiseman, GA
Burnett, OL
Spivey, JR
Therneau, T
Porayko, MK
Wiesner, RH
Citation: Mj. Krowka et al., Hepatopulmonary syndrome - A prospective study of relationships between severity of liver disease, Pao(2) response to 100% oxygen, and brain uptake after Tc-99m MAA lung scanning, CHEST, 118(3), 2000, pp. 615-624
Authors:
Wiseman, GA
White, CA
Witzig, TE
Gordon, LI
Emmanouilides, C
Raubitschek, A
Janakiraman, N
Gutheil, J
Schilder, RJ
Spies, S
Silverman, DHS
Grillo-Lopez, AJ
Citation: Ga. Wiseman et al., Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with Zevalin, a Y-90-labeled anti-CD20 monoclonal antibody, CLIN CANC R, 5(10), 1999, pp. 3281S-3286S
Authors:
Krowka, MJ
Wiseman, GA
Steers, JL
Wiesner, RH
Citation: Mj. Krowka et al., Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation, LIVER TR S, 5(5), 1999, pp. 451-453
Authors:
Witzig, TE
White, CA
Wiseman, GA
Gordon, LI
Emmanouilides, C
Raubitschek, A
Janakiraman, N
Gutheil, J
Schilder, RJ
Spies, S
Silverman, DHS
Parker, E
Grillo-Lopez, AJ
Citation: Te. Witzig et al., Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsedor refractory CD20(+) B-cell non-Hodgkin's lymphoma, J CL ONCOL, 17(12), 1999, pp. 3793-3803
Authors:
Howarth, DM
Gilchrist, GS
Mullan, BP
Wiseman, GA
Edmonson, JH
Schomberg, PJ
Citation: Dm. Howarth et al., Langerhans cell histiocytosis - Diagnosis, natural history, management, and outcome, CANCER, 85(10), 1999, pp. 2278-2290
Risultati:
1-10
|